4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Comprehensive Mapping of Electrophilic Small Molecule-Protein Interactions in Human Cells

      Preprint

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Covalent chemistry is a versatile approach for expanding the ligandability of the human proteome. Activity-based protein profiling (ABPP) can infer the specific residues modified by electrophilic compounds through competition with broadly reactive probes. Nonetheless, the extent to which such residue-directed ABPP platforms fully assess the protein targets of electrophilic compounds in human cells remains unclear. Here, we introduce a complementary approach that directly identifies proteins showing stereoselective reactivity with focused libraries of stereochemically-defined, alkynylated electrophilic compounds. Integration of protein- and cysteine-directed ABPP data from compound-treated human cancer cells revealed generally well-correlated target maps and highlighted specific features, such as protein size and the proteotypicity of cysteine-containing peptides, that help to explain gaps in each ABPP platform. The integrated ABPP strategy furnished stereoselective, high-engagement covalent ligands for > 300 structurally and functionally diverse human proteins, including compounds that modulate enzymes by canonical (active-site cysteine) and non-canonical (isotype-restricted and non-catalytic cysteines) mechanisms.

          Related collections

          Author and article information

          Contributors
          (View ORCID Profile)
          Journal
          American Chemical Society (ACS)
          June 05 2023
          Affiliations
          [1 ]Scripps R
          [2 ]Scripps Research Institute
          [3 ]Vividion Therapeutics (United States)
          [4 ]Broad Institute
          Article
          10.26434/chemrxiv-2023-s446n
          f3551b56-92af-47c1-a789-85492fb7d736
          © 2023

          https://creativecommons.org/licenses/by-nc-nd/4.0/

          History

          Comments

          Comment on this article